Novo Nordisk is suing a Shrewsbury doctor who sells a cheaper compounded medicine version of its popular Ozempic and Wegovy ...
Ivim Health reports hair loss from GLP-1 medications like Ozempic is typically temporary, linked to rapid weight loss, not the drugs.
Feb 23 (Reuters) - Novo Nordisk shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its ...
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
Ro CEO Zach Reitano joins ‘Mornings with Maria’ to discuss the launch of the Wegovy oral pill, the future of telehealth and ...
Doctors call Wegovy’s new weight loss pill a game changer in the fight against obesity, but some experts are urging patients to be cautious.
Eli Lilly’s win in a head-to-head trial drove Novo Nordisk’s market cap to pre-Wegovy levels not long after the victor became the first pharma company to top a $1 trillion valuation. It seems one ...
The obesity treatment landscape continues to evolve rapidly as demand for GLP-1--based therapies remains strong and competition intensifies. Novo Nordisk's December 2025 FDA approval of Wegovy(R) ...